MEDICUS PHARMA LTD. Payments of Financing Costs
MEDICUS PHARMA LTD. (MDCX) reported Payments of Financing Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-12
- MEDICUS PHARMA LTD. payments of financing costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- MEDICUS PHARMA LTD. payments of financing costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- MEDICUS PHARMA LTD. payments of financing costs for the quarter ending 2025-06-30 was $272.78K.
- MEDICUS PHARMA LTD. payments of financing costs for the quarter ending 2025-03-31 was $25.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $272.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $297.78K 10-Q · filed 2026-08-12 |
| 2025-03-31 | $25.00K 10-Q · filed 2026-05-14 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |